Table 2.
Subjects | Exercise | Hours | Fru dosages | Tracer | Blood glu (mmol/L) | Fru to glu conversion | Reference |
---|---|---|---|---|---|---|---|
9 M |
No |
6 |
3x0.3 g/kg bw |
13C-fru(L1) |
5.94%(2) |
37.4% |
|
9 F |
No |
6 |
3x0.3 g/kg bw |
13C-fru |
4.87%(2) |
28.9% |
[70] |
4 M + 4 F |
No |
3 |
3x0.3 g/kg bw |
13C-fru(L3) |
5.2 |
36.4%(3) |
|
7 obese F |
No |
3 |
3x0.3 g/kg bw |
13C-fru |
5.3 |
29.5%(3) |
|
8 type-2 (4 M) |
No |
3 |
3x0.3 g/kg bw |
13C-fru |
7.7 |
30.2%(3) |
[52] |
3 M + 3 F |
No |
6 |
0.5 g/kg bw |
13C-fru(L2) |
4.56 |
54.0% |
|
|
No |
6 |
1.0 g/kg bw |
13C-fru |
4.66 |
50.7% |
[49] |
3 M + 3 F |
No |
0-3 |
3 mg/kg/min4 |
13C-fru(L1) |
NA |
28.0%(4) |
|
|
No |
4-6 |
6 mg/kg/min4 |
13C-fru |
NA |
22.0%(4) |
[71] |
7 M |
Yes |
2 |
96 g fru + 144 g glu |
13C-fru(L1) |
6.2 |
29%(5) |
[51] |
6 M | Yes | 3 | 6x25 g | 13C-fru(L2) | NA | 55-60%(6) | [50] |
For superscript numbers: (1), except Jandrain’s study [50], the subjects in the other studies were under glucose infusion; Hours = study monitoring hours, fru = fructose, glu = glucose; bw = body weight; M = male, F = female; type-2 = type-2 diabetes; NA = not available. (2), increases from baseline. (3), data were calculated based on reported parameters. (4), fructose administrated by infusion. (5), under steady state of carbohydrate flux. (6), percent of circulating glucose in the 2nd half of study hours. In the column of “Tracer”, superscripted L1 = labeled uniformly, L2 = naturally enriched, and L3 = labeled at position 1.